CAS NO: | 1383450-81-4 |
生物活性 | Rilematovir (JNJ-678) is a novelfusion proteininhibitor. Rilematovir has the potential forrespiratory syncytial virus (RSV)research. | ||||||||||||||||
IC50& Target | Fusion protein[1] | ||||||||||||||||
体外研究 (In Vitro) | Rilematovir is a small-molecule respiratory syncytial virus (RSV) fusion inhibitor currently under clinical evaluation in infants hospitalized for RSV infection. Rilematovir binds to RSV F protein in its prefusion conformation. Rilematovir displays very potent antiviral activity and low cytotoxicity. In addition to its activity against the RSV A2 strain, Rilematovir is also highly active against a number of RSV strains from both A and B subtypes. The EC50in an RSV infection assay using HeLa cells is 460 pM[1]. | ||||||||||||||||
体内研究 (In Vivo) | Oral treatment of neonatal lambs with Rilematovir, or with an equally active close analog, efficiently inhibits established acute lower respiratory tract infection in the animals, even when treatment is delayed until external signs of respiratory syncytial virus illness have become visible[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 500.92 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C21H20ClF3N4O3S | ||||||||||||||||
CAS 号 | 1383450-81-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 65 mg/mL(129.76 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |